These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8950956)

  • 1. [Anti-allergic effects of beta-adrenoceptor agonists in the clinical pharmacological studies].
    Horikoshi S; Kokubu F; Adachi M
    Nihon Rinsho; 1996 Nov; 54(11):3068-72. PubMed ID: 8950956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.
    van der Woude HJ; Aalbers R
    Am J Respir Med; 2002; 1(1):55-74. PubMed ID: 14720076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
    Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
    Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.
    Källström BL; Sjöberg J; Waldeck B
    Br J Pharmacol; 1994 Nov; 113(3):687-92. PubMed ID: 7858856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK; Cooper E; Vardey CJ; Peachell PT
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of salmeterol.
    Johnson M; Butchers PR; Coleman RA; Nials AT; Strong P; Sumner MJ; Vardey CJ; Whelan CJ
    Life Sci; 1993; 52(26):2131-43. PubMed ID: 8099695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.
    Bissonnette EY; Befus AD
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):825-31. PubMed ID: 9438493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].
    Boulet LP
    Rev Mal Respir; 1992; 9 Suppl 1():R11-3. PubMed ID: 1350363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
    Butchers PR; Vardey CJ; Johnson M
    Br J Pharmacol; 1991 Nov; 104(3):672-6. PubMed ID: 1724629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variety of pharmacological action of beta agonists].
    Takahashi S; Kokubu F; Adachi M
    Arerugi; 1992 May; 41(5):557-62. PubMed ID: 1355646
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological action of SN-408, a novel long-acting selective beta 2-adrenoceptor agonist].
    Nishimura M; Okiyama M; Fujiwara H; Kudo M; Simizu M; Maeda M; Yamada M; Toshimitsu Y
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):7-21. PubMed ID: 1679741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological properties of salmeterol].
    Bousquet J; Michel FB
    Rev Mal Respir; 1992; 9 Suppl 1():R7-10. PubMed ID: 1350370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol inhibits anaphylactic histamine release from guinea-pig isolated mast cells.
    Gentilini G; Grazia di Bello M; Raspanti S; Bindi D; Mugnai S; Zilletti L
    J Pharm Pharmacol; 1994 Jan; 46(1):76-7. PubMed ID: 7515420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
    Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
    Yang Q; Battistini B; Pelletier S; Sirois P
    Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness.
    Tashimo H; Yamashita N; Ishida H; Nagase H; Adachi T; Nakano J; Yamamura K; Yano T; Yoshihara H; Ohta K
    Allergol Int; 2007 Sep; 56(3):241-7. PubMed ID: 17582211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-acting beta 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human.
    Lau HY; Wong PL; Lai CK; Ho JK
    Int Arch Allergy Immunol; 1994 Oct; 105(2):177-80. PubMed ID: 7522687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.